Higher Medication Adherence and Lower Opioid Use Among Individuals with Autoimmune Disease Enrolled in an Adalimumab Patient Support Program in the United States

INTRODUCTION: Opioid use is prevalent among patients with autoimmune conditions, despite not being a recommended treatment. Tumor necrosis factor inhibitor (anti-TNF) therapy is an effective treatment for these autoimmune conditions, and patient support programs (PSPs) have been developed to help pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Fendrick, A. Mark, Macaulay, Dendy, Goldschmidt, Debbie, Liu, Harry, Brixner, Diana, Ali, Tauseef, Mittal, Manish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217395/
https://www.ncbi.nlm.nih.gov/pubmed/33899166
http://dx.doi.org/10.1007/s40744-021-00309-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217395/
https://www.ncbi.nlm.nih.gov/pubmed/33899166
http://dx.doi.org/10.1007/s40744-021-00309-9

Ejemplares similares